Lumen Bioscience
PrivateLast Round
Series C
Extension
Oct 8, 2025
Total Funding Raised
$126.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lumen Bioscience is a biotechnology company that develops oral biologic drugs and vaccine candidates using a proprietary spirulina-based platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Clean Manufacturing
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumen Bioscience Comparables
Compare Lumen Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vedanta Biosciences | 79% | |
| Fzata, Inc. | 78% | |
| GAT Biosciences S.L. | 78% | |
Lumen Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Oct 8, 2025 | ||||
| Grant | Oct 17, 2023 | ||||
| Series C | Jun 1, 2022 | ||||
| Grant | Jan 27, 2021 | ||||
| Series B | Sep 1, 2020 | ||||
Grant | Dec 5, 2017 |
Lumen Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| U.S. Department of Defense | Grant |
| Gates Family Foundation | Series C Extension |
| Gates Foundation | Grant, Series C Extension |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| WestRiver Group | Series C Extension, Series B |
| U.S. Department of War | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 51% MoM, from 3.7K to 5.6K.
- Mar 10, 2026
Achieved FSCC 22000 food safety certification.
Lumen Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumen Bioscience's valuation, stock price, and market status.